Candriam S.C.A. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$21,044,000
+222.3%
144,428
+207.3%
0.17%
+293.2%
Q3 2021$6,529,000
+43.1%
47,0050.0%0.04%
+41.9%
Q2 2021$4,563,000
+12.9%
47,005
-4.2%
0.03%
-8.8%
Q1 2021$4,040,000
-3.9%
49,0670.0%0.03%
+3.0%
Q4 2020$4,206,000
-58.8%
49,067
-68.7%
0.03%
-65.6%
Q3 2020$10,199,000
-19.3%
156,887
-9.2%
0.10%
-27.8%
Q2 2020$12,634,000
+25.7%
172,799
-8.5%
0.13%
+19.8%
Q1 2020$10,047,000
-2.2%
188,7990.0%0.11%
+0.9%
Q4 2019$10,278,000
-41.3%
188,799
-55.0%
0.11%
-52.6%
Q3 2019$17,514,000
-12.3%
419,799
-8.3%
0.23%
-6.8%
Q2 2019$19,959,000
-12.4%
457,799
+3.4%
0.25%
-14.7%
Q1 2019$22,792,000
+12.5%
442,799
-19.2%
0.29%
-6.1%
Q4 2018$20,257,000
+29.3%
547,799
+31.3%
0.31%
+49.5%
Q3 2018$15,670,000
+91.4%
417,299
+101.5%
0.21%
+60.0%
Q2 2018$8,185,000
+202.6%
207,099
+97.2%
0.13%
+182.6%
Q1 2018$2,705,000
+25.3%
105,000
+31.2%
0.05%
+24.3%
Q4 2017$2,158,00080,0000.04%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2018
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$154,344,00072.03%
Knoll Capital Management, LLC 856,844$119,024,00059.36%
ORACLE INVESTMENT MANAGEMENT INC 2,124,055$295,053,00036.73%
ARS Investment Partners, LLC 466,668$64,825,0006.49%
KINGDON CAPITAL MANAGEMENT, L.L.C. 365,373$50,754,0006.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$24,490,0005.91%
SILVERARC CAPITAL MANAGEMENT, LLC 61,897$8,598,0004.86%
DAFNA Capital Management LLC 88,100$12,238,0003.25%
Avidity Partners Management LP 934,200$129,770,0002.88%
Eventide Asset Management 1,325,000$184,056,0002.43%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders